Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Rgs20em1/Cya
Common Name:
Rgs20-KO
Product ID:
S-KO-11076
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Rgs20-KO
Strain ID
KOCMP-58175-Rgs20-B6J-VA
Gene Name
Rgs20
Product ID
S-KO-11076
Gene Alias
2900073E09Rik; Rgsz1
Background
C57BL/6JCya
NCBI ID
58175
Modification
Conventional knockout
Chromosome
1
Phenotype
MGI:1929866
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Rgs20em1/Cya mice (Catalog S-KO-11076) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000118000
NCBI RefSeq
NM_001177795
Target Region
Exon 3
Size of Effective Region
~1.2 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Rgs20, short for Regulator of G protein signaling 20, is a member of the RGS protein superfamily. RGS proteins act as key negative regulators of G protein-mediated signal transduction, and Rgs20, through its GTPase accelerating protein (GAP) activity, deactivates α-subunits of heterotrimeric G proteins. It can also act through non-GAP related functions and is involved in regulating Gαz and Gi/o-mediated signaling [4]. Palmitoylation, an important post-translational modification, is a regulatory mechanism controlling Rgs20 function [4].

In multiple cancers, Rgs20 has been found to play oncogenic roles. In penile cancer, high Rgs20 expression is associated with tumor stage, nodal status, and pelvic metastasis. It promotes tumor progression by modulating PI3K/AKT signaling activation [2]. In non-small cell lung carcinoma, higher Rgs20 expression is correlated with a poorer five-year survival rate, and it drives cell proliferation by triggering autophagy via the inhibition of PKA-Hippo signaling [3]. In renal cell carcinoma, high Rgs20 expression is closely associated with the progression and immune infiltration, and knockdown of Rgs20 impairs cell proliferation, migration, and invasiveness [5]. In hepatocellular carcinoma, miR-204-5p inhibits the disease by targeting and downregulating Rgs20 expression [6]. In triple-negative breast cancer, Rgs20 is upregulated in lymph node-positive cases, and high expression is associated with lymph node metastasis and poor relapse-free survival [7]. In oral squamous cell carcinoma, lncRNA NEAT1 promotes cell proliferation and invasion by regulating miR-365/Rgs20 axis [8]. Also, in lung adenocarcinoma, the transcription factor SP1 activates Rgs20 expression through super-enhancers to promote cancer progression [1].

In conclusion, Rgs20 is an important regulator in G protein-mediated signal transduction. Its abnormal expression is closely associated with the progression and prognosis of multiple cancers, including penile, lung, renal, hepatocellular, triple-negative breast, and oral squamous cell carcinomas. These findings from in vivo and in vitro studies provide insights into Rgs20's role in cancer biology, suggesting it could be a potential target for cancer therapies.

References:

1. Shan, Liying, Wang, Wenmeng, Du, Lijuan, Sui, Guangchao, Liu, Fang. 2024. SP1 undergoes phase separation and activates RGS20 expression through super-enhancers to promote lung adenocarcinoma progression. In Proceedings of the National Academy of Sciences of the United States of America, 121, e2401834121. doi:10.1073/pnas.2401834121. https://pubmed.ncbi.nlm.nih.gov/38976739/

2. Shi, Dazun, Tong, Shiyu, Han, Hui, Hu, Xiheng. 2022. RGS20 Promotes Tumor Progression through Modulating PI3K/AKT Signaling Activation in Penile Cancer. In Journal of oncology, 2022, 1293622. doi:10.1155/2022/1293622. https://pubmed.ncbi.nlm.nih.gov/35498542/

3. Ding, Xiaoyan, Li, Xiaoxia, Jiang, Yanxia, Li, Bing, Zhao, Robert Chunhua. 2024. RGS20 promotes non-small cell lung carcinoma proliferation via autophagy activation and inhibition of the PKA-Hippo signaling pathway. In Cancer cell international, 24, 93. doi:10.1186/s12935-024-03282-9. https://pubmed.ncbi.nlm.nih.gov/38431606/

4. Zhang, Qian, Sjögren, Benita. 2023. Palmitoylation of RGS20 affects Gαo-mediated signaling independent of its GAP activity. In Cellular signalling, 107, 110682. doi:10.1016/j.cellsig.2023.110682. https://pubmed.ncbi.nlm.nih.gov/37075876/

5. Jiang, Lin, Shen, Jiangwei, Zhang, Ning, He, Yongchao, Wan, Zhenghua. 2021. Association of RGS20 expression with the progression and prognosis of renal cell carcinoma. In Oncology letters, 22, 643. doi:10.3892/ol.2021.12904. https://pubmed.ncbi.nlm.nih.gov/34386065/

6. Su, Yanqing, Lu, Yao, An, Honglin, Huang, Bin, Lin, Jiumao. 2023. MicroRNA-204-5p Inhibits Hepatocellular Carcinoma by Targeting the Regulator of G Protein Signaling 20. In ACS pharmacology & translational science, 6, 1817-1828. doi:10.1021/acsptsci.3c00114. https://pubmed.ncbi.nlm.nih.gov/38093845/

7. Li, Quan, Jin, Wenxu, Cai, Yefeng, Wang, Qingxuan, Guan, Xiaoxiang. 2017. Regulator of G protein signaling 20 correlates with clinicopathological features and prognosis in triple-negative breast cancer. In Biochemical and biophysical research communications, 485, 693-697. doi:10.1016/j.bbrc.2017.02.106. https://pubmed.ncbi.nlm.nih.gov/28237701/

8. Huang, Gang, He, Xin, Wei, Xin-Li. 2018. lncRNA NEAT1 promotes cell proliferation and invasion by regulating miR‑365/RGS20 in oral squamous cell carcinoma. In Oncology reports, 39, 1948-1956. doi:10.3892/or.2018.6283. https://pubmed.ncbi.nlm.nih.gov/29484420/

Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest